It was reported that in the post-prostatectomy samples patients had increased T-cells at the cancer margin as compared with the biopsy sample, but only those patients who had had prior treatment with Sipuleucel-T, which increased the number of CD4+ FOXP3—helper T-cells and cytotoxic T-cells. The gene discussed is FOXP3; the disease is cancer.